Company Profile

Quzyme LLC
Profile last edited on: 8/29/07      CAGE: 47S02      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2004
First Award
2006
Latest Award
2006
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1619 NE 366th Avenue
Corbett, OR 97019
   (503) 351-2597
   ReuylD@comcast.net
   N/A
Location: Single
Congr. District: 03
County: Multnomah

Public Profile

President of Quzyme is Dr. Iwata-Reuyl. His research interests are in the area of modern biological chemistry, and include the chemistry and enzymology of RNA modification, the role of modified nucleosides in RNA function, the biosynthetic pathways of secondary metabolism, the molecular genetics of biosynthetic pathways, and protein/nucleic acid interactions. At present his group is investigating the biochemistry of the hypermodified nucleosides queuosine and archaeosine, which are present in specific transfer RNA molecules. Transfer RNA (tRNA) is structurally unique among nucleic acids in harboring an astonishing diversity of modified nucleosides, many of which are highly conserved in type and location across broad phylogenetic boundaries. Arguably the most remarkable modifications known to occur in tRNA are the hypermodified nucleosides queuosine and archaeosine. Although both nucleosides share an unusual 7-deazaguanosine core structure, they are rigorously segregated with respect to phyla, location in the tRNA, and presumed function; queuosine is ubiquitous throughout the Bacteria and Eukarya where it occurs specifically at the wobble position in a subset of tRNA's. Its location in the anticodon suggests a role in modulating translational fidelity and/or efficiency. Archaeosine is found exclusively in the Archae, and is located at position 15 of the D-loop in the majority of known archaeal tRNA's. Its position at a critical interface of the D-loop and T-stem in the tertiary structure of the tRNA suggests a role in maintaining the structural integrity of the tRNA. The work currently underway in Dr. Iwata-Reuyl's laboratory is focused on discovering and characterizing the enzymes responsible for the biosynthesis of queuosine and archaeosine, developing an understanding of their biochemical mechanisms, and addressing specific functional questions. These investigations incorporate diverse experimental methodologies, from enzymology and molecular biology, to synthetic and physical organic chemistry.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2006 1 NIH $99,700
Project Title: A Biocatalytic Route to Nitrile Reduction

Key People / Management

  Dirk Iwata-Reuyl

Company News

There are no news available.